Symphony Financial’s Chemours CC Stock Holding History

Symphony Financial’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,199	Closed	-$464K	–	193
2022 Q3	$464K	Buy	+19,199	New	+$633K	0.15%	141

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Symphony Financial's CC Position: Q4 2022 in Review

Symphony Financial sold out of Chemours (CC) in Q4 2022, closing a stake of 19,199 shares — an estimated $464K sold.

Symphony Financial first reported a position in CC in Q3 2022 and held it in 1 quarter. The position peaked at $464K in Q3 2022. 473 funds tracked by Wall St. Rank hold CC as of Q4 2022.

Symphony Financial reported no remaining Chemours position as of Q4 2022 after selling out during the quarter.
Symphony Financial sold 19,199 Chemours shares in Q4 2022, an estimated $464K.
Symphony Financial first reported a position in Chemours in Q3 2022 and held it in 1 quarter.
Symphony Financial's Chemours position peaked at $464K in Q3 2022.
473 funds tracked by Wall St. Rank held Chemours as of Q4 2022.

Based on Symphony Financial's 13F filing for Q4 2022, filed 26 Jan 2023.